Document is current
Any future updates will be listed below
-
Authors
Yu, Jie
Liu, Han
Chen, Yu
Wang, Ling
Chen, Peng
Zhao, Yue
Ou, Chunxia
Chen, Wei
Hu, Jie
Wang, Yu
Wang, Yan
-
Funding
Funding for this research was provided by:
The National Natural Science Foundation of China (82160076)
Ten Thousand Talent Plans for Young Top-notch Talents of Yunnan Province (RLQB20220011)
Yunnan Provincial Department of Science and Technology (202301AT070093)
Special Foundation Projects of Joint Applied Basic Research of Yunnan Provincial Department of Science and Technology with Kunming Medical University (202201AY070001-062)
535 Talent Project of First Affiliated Hospital of Kunming Medical University (2023535Q04)
- License Information
-
More Information
Article History
Received: 19 February 2024
Accepted: 28 March 2024
First Online: 8 May 2024
Declarations
:
: All animal experiments were performed with the help of Yunan Labreal Biotech Ltd, co. in accordance with the ARRIVE principles and were approved by the Animal Care and Use Committee of the Yunan Labreal Biotech Ltd, co. with the details as follows: (1)Title of the approved project: miR-449a disturbs atherosclerotic plaque stability in streptozotocin and high-fat diet-induced diabetic mice by targeting CEACAM1 (2) Name of the institutional approval committee or unit: Yunan Labreal Biotech Ltd, co; (3) Approval number: No. PZ20230109; (4) Date of approval.:2023/01/05.
: Not applicable.
: The Yunan Labreal Biotech Ltd, co. provided the research materials in the animal experiment. Although the animal experiment was performed in the platform of a private company, they did not aware of or interfere the experimental propose and not participate in the writing, review, and publication of this manuscript. No economic interests were appeared.
